APA

Goodgame J. C., Pottage J. C., Jablonowski H., Hardy W. D., Stein A., Fischl M., Morrow P., Feinberg J., Brothers C. H., Vafidis I., Nacci P., Yeo J. & Pedneault L. (20010531). Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team. : Antiviral therapy.

Chicago

Goodgame J C, Pottage J C, Jablonowski H, Hardy W D, Stein A, Fischl M, Morrow P, Feinberg J, Brothers C H, Vafidis I, Nacci P, Yeo J and Pedneault L. 20010531. Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team. : Antiviral therapy.

Harvard

Goodgame J. C., Pottage J. C., Jablonowski H., Hardy W. D., Stein A., Fischl M., Morrow P., Feinberg J., Brothers C. H., Vafidis I., Nacci P., Yeo J. and Pedneault L. (20010531). Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team. : Antiviral therapy.

MLA

Goodgame J C, Pottage J C, Jablonowski H, Hardy W D, Stein A, Fischl M, Morrow P, Feinberg J, Brothers C H, Vafidis I, Nacci P, Yeo J and Pedneault L. Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team. : Antiviral therapy. 20010531.